Groowe Groowe BETA

US Stock Market News

Stay on top of the US stock market with real-time breaking news and market-moving stories. Our platform continuously aggregates updates from trusted financial news sources, giving traders and investors a fast overview of events that may impact stock prices.

Whether you're tracking specific companies or scanning the broader market, the news feed helps you quickly identify important developments as they happen.

Create an account to access the live news feed. Access is free while the platform is in beta. Visitors without an account can still browse the latest headlines with a 15-minute delay.

⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

HYLN INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Hyliion Investors of Securities Class Action Lawsuit Deadline on October 27, 2026 Ready to Announce with Confidence?

newsfilecorp.com
HYLN

CELH INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Celsius Holdings Investors of Securities Class Action Lawsuit Deadline on November 3, 2026 Ready to Announce with Confidence?

newsfilecorp.com
CELH

Did You Lose Money on Honeywell Aerospace Inc. (HONA)? Levi & Korsinsky Urges Investors to Act Before November 23, 2026

accessnewswire.com
HONA HON

Levi & Korsinsky Urges Papa John's (PZZA) Shareholders to Act Before Lead Plaintiff Deadline November 2, 2026

accessnewswire.com
PZZA

Class Action Lawsuit Filed Against HDFC Bank Limited (HDB) – Recover Losses – Contact Levi & Korsinsky Before October 13, 2026

accessnewswire.com
HDB

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Honeywell Aerospace Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HONA

globenewswire.com
HONA HON

ROSEN, REGARDED INVESTOR COUNSEL, Encourages Papa John’s International, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PZZA

globenewswire.com
PZZA

Agenus informa una supervivencia estimada a tres años del 48 % con BOT+BAL para cáncer de ovarios recurrente en IGCS 2026

businesswire.com
AGEN

Agenus annonce à l'IGCS 2026 une survie à trois ans estimée à 48 % avec BOT+BAL dans le cancer de l'ovaire récurrent

businesswire.com
AGEN

Barclays Investor News: If You Have Suffered Losses in Barclays PLC (NYSE: BCS), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

globenewswire.com
BCS
View all news →